New interview with Prof. Güralp Ceyhan, MD. details advances in pancreatic cancer therapy at Acibadem Maslak and Altunizade Hospital
ISTANBUL, Dec.14, 2020 / PRNewswire / – New advancements in pancreatic cancer research have led to innovative treatment programs available at Acibadem Maslak and Altunizade Hospital, part of Acibadem’s global network of class health centers world. Because the treatment of pancreatic cancer requires a complex, multidisciplinary approach, oncologists, radiation oncologists, and gastroenterologists enlist in the hospital. In a new interview, Prof. Güralp Ceyhan, MD details the hospital’s innovative therapies now available for pancreatic cancer patients who were previously thought to be without treatment options.
https://mma.prnewswire.com/media/1360896/Dr_Guralp_Onur_Ceyhan.jpg [https://mma.prnewswire.com/media/1360896/Dr_Guralp_Onur_Ceyhan.jpg]
In the interview, Prof. Ceyhan, a physician at Acibadem Maslak and Altunizade Hospital, reviewed the treatment methodologies available for cancer patients affected by one of the most dangerous forms of the disease. Worldwide, almost 250,000 new patients were diagnosed with malignant tumors that affected the pancreas in 2018. Due to the nature of the disease, early detection of pancreatic cancer remains a difficult process, narrowing the crucial window of treatment.
To learn more about Acibadem services, visit: https://acibademinternational.com/treatment/cancer-treatment-oncology/ [https://acibademinternational.com/treatment/cancer-treatment-oncology/]
Symptoms of pancreatic cancer:
– Yellow, jaundice of the skin – Very severe and radiating back pain – Sudden onset diabetes
The difficulties of early detection
According to Prof. Ceyhan, early detection is almost impossible. “Only by chance can we detect pancreatic cancer at an early stage: the patient goes for a checkup and the doctor sees something on the ultrasound and then the diagnosis is confirmed through CT,” Prof. Ceyhan said.
Video of the day |
The US starts the campaign to administer the Pfizer vaccine. |
–
“Pancreatic cancer remains a dangerous disease,” continues Prof. Ceyhan. “But now we can help patients that we would not have thought of being able to help in the past. We are getting better and better, but pancreatic cancer is unfortunately still a very aggressive and deadly tumor. What we have gained now is more hope. for our patients. “
Because pancreatic surgery is a difficult and intensive process, Acibadem maintains a highly qualified team of physicians who are experts in a multidisciplinary approach to defeat the disease, using the latest technologies and advancements, even in the midst of the COVID-19 pandemic. . Acibadem has carefully isolated its cancer center from COVID-related services at the hospital, ensuring that cancer patients can receive maximum care in a COVID-free environment.
Hope for patients at Acibadem
Acibadem Maslak and Altunizade Hospital’s multidisciplinary teams provide state-of-the-art treatments for pancreatic cancer patients (including patients with chronic pancreatitis and advanced liver tumors). Some of the modern therapy protocols in the hospital include neoadjuvant chemotherapy regimens that slow tumor growth and progression, allowing doctors to remove pancreatic cancer patients who in the past were considered lost patients.
About Acibadem Healthcare Group
Acibadem Healthcare Group [https://acibademinternational.com/why-acibadem/] was established in 1991, quickly becoming one of the leading institutions in Turkey in the field of private health services. In 2012 the company partnered with IHH Healthcare Berhad. This measure made Acibadem the second largest health chain in the world with 21 hospitals and 13 outpatient clinics, as well as 11 cancer centers. All centers are nationally and internationally accredited and qualified.
Photo – https://mma.prnewswire.com/media/1360896/Dr_Guralp_Onur_Ceyhan.jpg [https://mma.prnewswire.com/media/1360896/Dr_Guralp_Onur_Ceyhan.jpg] Logo – https://mma.prnewswire.com/media/1360502/Acibadem.jpg [https://mma.prnewswire.com/media/1360502/Acibadem.jpg]
https://mma.prnewswire.com/media/1360502/Acibadem.jpg [https://mma.prnewswire.com/media/1360502/Acibadem.jpg]
CONTACT: CONTACT: Deniz Sentop, +905323113214, [email protected]
Website: https://acibademinternational.com/
– .